Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Dec;104(4):973–977. doi: 10.1111/j.1476-5381.1991.tb12535.x

The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.

N J Hayward 1, M Harding 1, S A Lloyd 1, A T McKnight 1, J Hughes 1, G N Woodruff 1
PMCID: PMC1908834  PMID: 1687371

Abstract

1. The urethane-anaesthetized, vagotomised rat preparation was used to investigate the effects of the histamine H2-antagonist ranitidine, the proton pump inhibitor omeprazole and the CCKB/gastrin antagonists CI-988, PD 136450 and L-365,260 on pentagastrin-, histamine- and bethanechol-induced gastric acid secretion. 2. The novel CCKB/gastrin antagonists CI-988 and PD 136450, and L-365,260 dose-dependently inhibited pentagastrin-induced secretion. The ED50 value for PD 136450 was 0.05 mumol kg-1, the same following intravenous or subcutaneous administration. 3. CI-988 and PD 136450 administered subcutaneously at dose levels highly effective for antagonism of pentagastrin responses had no effect on basal acid secretion. 4. Ranitidine inhibited pentagastrin-, bethanechol-, and histamine-induced acid secretion, whereas the CCKB/gastrin antagonists inhibited only the secretory response to pentagastrin. 5. The selective CCKA antagonist, devazepide, was inactive at up to 300 mumol kg-1 i.p. against the three stimulants of acid secretion. 6. CI-988 and PD 136450 will be useful research tools with which to investigate the role of CCKB/gastrin receptors in gastric acid secretion and the trophic activities of gastrin and cholecystokinin (CCK) on the gastrointestinal tract.

Full text

PDF
973

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albinus M., Sewing K. F. The effect of SC-15396, atropine and mepyramine on gastrin-, bethanechol- and histamine-stimulated gastric acid secretion in rats and guinea-pigs. J Pharm Pharmacol. 1969 Oct;21(10):656–661. doi: 10.1111/j.2042-7158.1969.tb08141.x. [DOI] [PubMed] [Google Scholar]
  2. Black J. W., Shankley N. P. The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br J Pharmacol. 1985 Nov;86(3):571–579. doi: 10.1111/j.1476-5381.1985.tb08933.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bock M. G., DiPardo R. M., Evans B. E., Rittle K. E., Whitter W. L., Veber D. E., Anderson P. S., Freidinger R. M. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. J Med Chem. 1989 Jan;32(1):13–16. doi: 10.1021/jm00121a004. [DOI] [PubMed] [Google Scholar]
  4. Bunce K. T., Parsons M. E. Inhibition by metiamide of secretagogue-induced gastric acid secretion in the conscious Heidenhain pouch rat. J Physiol. 1978 Dec;285:49–57. doi: 10.1113/jphysiol.1978.sp012556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bunce K. T., Parsons M. E. The effect of hexamethonium on gastric acid secretion in the conscious rat. Agents Actions. 1977 Dec;7(5-6):507–511. doi: 10.1007/BF02111122. [DOI] [PubMed] [Google Scholar]
  6. Chang R. S., Lotti V. J. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4923–4926. doi: 10.1073/pnas.83.13.4923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chang R. S., Lotti V. J., Monaghan R. L., Birnbaum J., Stapley E. O., Goetz M. A., Albers-Schönberg G., Patchett A. A., Liesch J. M., Hensens O. D. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science. 1985 Oct 11;230(4722):177–179. doi: 10.1126/science.2994227. [DOI] [PubMed] [Google Scholar]
  8. Code C. F. Histamine and gastric secretion: a later look, 1955-1965. Fed Proc. 1965 Nov-Dec;24(6):1311–1321. [PubMed] [Google Scholar]
  9. Daly M. J., Humphray J. M., Stables R. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine. Br J Pharmacol. 1981 Jan;72(1):49–54. doi: 10.1111/j.1476-5381.1981.tb09103.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ekblad E. B. Histamine: the sole mediator of pentagastrin-stimulated acid secretion. Acta Physiol Scand. 1985 Sep;125(1):135–143. doi: 10.1111/j.1748-1716.1985.tb07700.x. [DOI] [PubMed] [Google Scholar]
  11. Evans B. E., Bock M. G., Rittle K. E., DiPardo R. M., Whitter W. L., Veber D. F., Anderson P. S., Freidinger R. M. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4918–4922. doi: 10.1073/pnas.83.13.4918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GHOSH M. N., SCHILD H. O. Continuous recording of acid gastric secretion in the rat. Br J Pharmacol Chemother. 1958 Mar;13(1):54–61. doi: 10.1111/j.1476-5381.1958.tb00190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grossman M. I., Konturek S. J. Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. Gastroenterology. 1974 Apr;66(4):517–521. [PubMed] [Google Scholar]
  14. HAVERBACK B. J., TECIMER L. B., DYCE B. J., COHEN M., STUBRIN M. I., SANTAANA A. D. THE EFFECT OF GASTRIN ON STOMACH HISTAMINE IN THE RAT. Life Sci. 1964 Jun;3:637–649. doi: 10.1016/0024-3205(64)90178-x. [DOI] [PubMed] [Google Scholar]
  15. Hedges A. R., Parsons M. E. The effect of anaesthesia on the inhibition of pentagastrin-evoked gastric acid secretion induced by atropine in the rat. J Physiol. 1977 May;267(1):181–194. doi: 10.1113/jphysiol.1977.sp011807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hirst B. H., Elliott K. J., Ryder H., Szelke M. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat. Aliment Pharmacol Ther. 1991 Feb;5(1):31–39. doi: 10.1111/j.1365-2036.1991.tb00003.x. [DOI] [PubMed] [Google Scholar]
  17. Horwell D. C., Hughes J., Hunter J. C., Pritchard M. C., Richardson R. S., Roberts E., Woodruff G. N. Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties. J Med Chem. 1991 Jan;34(1):404–414. doi: 10.1021/jm00105a062. [DOI] [PubMed] [Google Scholar]
  18. Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D. C., Hunter J. C., Pinnock R. D., Woodruff G. N. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6728–6732. doi: 10.1073/pnas.87.17.6728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Häkanson R., Larsson L. I., Liedberg G., Oscarson J., Sundler F., Vang J. Effects of antrectomy or porta-caval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study. J Physiol. 1976 Aug;259(3):785–800. doi: 10.1113/jphysiol.1976.sp011495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Håkanson R., Liedberg G. The role of endogenous gastrin in the activation of gastric histidine decarboxylase in the rat. Effect of antrectomy and vagal denervation. Eur J Pharmacol. 1970 Sep 1;12(1):94–103. doi: 10.1016/0014-2999(70)90033-6. [DOI] [PubMed] [Google Scholar]
  21. Kahlson G., Rosengren E. Histamine: entering physiology. Experientia. 1972 Sep 15;28(9):993–1002. doi: 10.1007/BF01918636. [DOI] [PubMed] [Google Scholar]
  22. Kahlson G., Rosengren E. New approaches to the physiology of histamine. Physiol Rev. 1968 Jan;48(1):155–196. doi: 10.1152/physrev.1968.48.1.155. [DOI] [PubMed] [Google Scholar]
  23. Lotti V. J., Chang R. S. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol. 1989 Mar 21;162(2):273–280. doi: 10.1016/0014-2999(89)90290-2. [DOI] [PubMed] [Google Scholar]
  24. Magous R., Bali J. P. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells. Regul Pept. 1983 Nov;7(3):233–241. doi: 10.1016/0167-0115(83)90016-2. [DOI] [PubMed] [Google Scholar]
  25. Main I. H., Pearce J. B. Increased histamine-output from the isolated gastric mucosa of the rat in response to pentagastrin and methacholine. Br J Pharmacol. 1982 May;76(1):51–59. doi: 10.1111/j.1476-5381.1982.tb09190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rovati A. L. Inhibition of gastric secretion by anti-gastrinic and H2-blocking agents. Scand J Gastroenterol Suppl. 1976;42:113–118. [PubMed] [Google Scholar]
  27. Soll A. H. Studies on the actions and interactions of secretagogues on isolated mammalian parietal cells as reflected in changes in oxygen consumption and aminopyrine uptake. Gastroenterology. 1977 Oct;73(4 Pt 2):899–899. [PubMed] [Google Scholar]
  28. Stechschulte D. J., Jr, Morris D. C., Jilka R. L., Stechschulte D. J., Dileepan K. N. Impaired gastric acid secretion in mast cell-deficient mice. Am J Physiol. 1990 Jul;259(1 Pt 1):G41–G47. doi: 10.1152/ajpgi.1990.259.1.G41. [DOI] [PubMed] [Google Scholar]
  29. Tharp M. D., Thirlby R., Sullivan T. J. Gastrin induces histamine release from human cutaneous mast cells. J Allergy Clin Immunol. 1984 Aug;74(2):159–165. doi: 10.1016/0091-6749(84)90280-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES